Clinical Trials Logo

Citation(s)

PHASE 2, Multi-center, Single Arm Investigation of HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

Details for clinical trial NCT00905060